Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic ...

Hospira, Inc., has issued a nationwide Vancomycin Injection recall over concerns about the presence of glass particulates in the vials. New York-based Hospira Pharma is affiliated with international ...

(RTTNews) - Glenmark Pharmaceuticals Inc., USA, affiliated to India-based Glenmark Pharmaceuticals Ltd., announced Tuesday the launch of Vancomycin Hydrochloride for Injection USP in single-dose vials ...

PHILADELPHIA, Aug. 28, 2018 /PRNewswire-PRWeb/ -- Pentec Health, Inc., an established leader in patient-specific and sterile compounding (503A), announced the availability of multiple products using ...

Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. The bactericidal action of vancomycin results primarily from inhibition of cell-wall ...

Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Vancomycin Hydrochloride Injection, USP, 1.5 g/vial Single Dose Flip-top Vial, lot 33045BA, to the user level due to two visible ...

Guidelines recommend against use of midline catheters for vancomycin-based outpatient parenteral antimicrobial therapy (OPAT), but evidence supporting the guidance is limited. This retrospective study ...

Vancomycin has only rarely been implicated as a cause of thrombocytopenia, and there is only limited evidence that this complication is caused by immune mechanisms. We conducted a study to determine ...

Glenmark Pharmaceuticals Inc., USA (Glenmark), a research-led, global pharmaceutical company, announces the launch of vancomycin hydrochloride for injection USP, 750 mg/vial, 1.25 g/vial and 1.5 ...

Glenmark is introducing vancomycin hydrochloride for injection, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial), which is the generic of Mylan’s Vancomycin Hydrochloride for Injection.